Carlo Schneider
Overview
Explore the profile of Carlo Schneider including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
148
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Schneider C, Fassbender P, Leers J
Dtsch Arztebl Int
. 2022 Aug;
119(19):341.
PMID: 35974461
No abstract available.
2.
Vogt A, Sadeghlar F, Ayub T, Schneider C, Mohring C, Zhou T, et al.
Cancers (Basel)
. 2021 Jul;
13(13).
PMID: 34282787
Dendritic cells (DC) as professional antigen presenting cells are able to prime T-cells against the tumor-associated antigen α-fetoprotein (AFP) for immunotherapy of hepatocellular carcinoma (HCC). However, a strong immunosuppressive tumor...
3.
Heymann F, Niemietz P, Peusquens J, Ergen C, Kohlhepp M, Mossanen J, et al.
J Vis Exp
. 2015 Apr;
(97).
PMID: 25866988
Liver inflammation as a response to injury is a highly dynamic process involving the infiltration of distinct subtypes of leukocytes including monocytes, neutrophils, T cell subsets, B cells, natural killer...
4.
Schneider C, Tacke F
Oncoimmunology
. 2012 Nov;
1(6):937-939.
PMID: 23162763
Hepatocellular carcinoma (HCC) commonly arises in chronically inflamed livers, but may also provoke (anti-tumoral) immune responses. Using non-inflammatory diethylnitrosamine (DEN)-induced liver cancer in mice, we demonstrate that distinct axes of...
5.
Koch A, Zimmermann H, Baeck C, Schneider C, Yagmur E, Trautwein C, et al.
Clin Biochem
. 2012 Jan;
45(6):429-35.
PMID: 22285383
Objectives: C-type natriuretic peptide (CNP) might be an important regulator of vasodilatation, fluid and sodium balance in liver cirrhosis. We aimed at assessing its regulation and prognostic relevance in liver...
6.
Schneider C, Teufel A, Yevsa T, Staib F, Hohmeyer A, Walenda G, et al.
Gut
. 2012 Jan;
61(12):1733-43.
PMID: 22267597
Background: Hepatocellular carcinoma (HCC) is a typical inflammation-associated cancer, but may also provoke antitumour immune responses whose significance and underlying mechanisms are incompletely understood. Objective: To characterise immune responses in...
7.
Gonzalez-Carmona M, Vogt A, Heinicke T, Quasdorff M, Hoffmann P, Yildiz Y, et al.
J Hepatol
. 2010 Dec;
55(1):19-28.
PMID: 21145870
Background & Aims: In this study, adenoviral vectors encoding an antisense RNA complementary to the 5' non-coding region (5'NCR) of the HCV-genome were generated to inhibit HCV-RNA gene expression in...
8.
Gonzalez-Carmona M, Marten A, Hoffmann P, Schneider C, Sievers E, Schmidt-Wolf I, et al.
Liver Int
. 2006 Apr;
26(3):369-79.
PMID: 16584401
Background/aims: Breaking immunologic tolerance towards the hepatocellular carcinoma (HCC)-associated alpha-fetoprotein (AFP) antigen is possible. The use of this potential for the treatment of immunocompromised HCC patients is limited. In this...